Literature DB >> 17215594

Lifelong course of positive and negative symptoms in chronically institutionalized patients with schizophrenia.

Branislav Mancevski1, John Keilp, Matthew Kurzon, Robert M Berman, Vladimir Ortakov, Jill Harkavy-Friedman, Gorazd Rosoklija, Andrew J Dwork.   

Abstract

BACKGROUND: Despite widespread policies of deinstitutionalization, a substantial number of patients with schizophrenia require continuous custodial care. The hospital records of such patients provide contemporaneous documentation of symptoms throughout the illness, permitting a longitudinal study of the course of symptoms. We sought to describe this course, and to determine the influences of sex, age of onset, and treatment on its evolution.
METHODS: Using the modified Diagnostic Evaluation After Death, we performed standardized chart reviews of 99 chronic inpatients who remained in state institutions through the 1960's and 1970's and subsequently died in those institutions. Data were available from the onset of illness until death.
RESULTS: We found significant decreases in positive symptoms and increases in negative symptoms over the course of the illness. Symptom patterns were analyzed by repeated measures ANOVA. Onset before age 25 was associated with greater numbers of negative symptoms at a given age (p = 0.05). Female sex was associated with greater numbers of positive symptoms (p=0.04). The widespread introduction of neuroleptic drugs in the mid-1950's did not affect the trends in symptom patterns.
CONCLUSIONS: The lifetime course of schizophrenia in chronically institutionalized individuals is characterized by a decrease in positive symptoms and an increase in negative symptoms. Schizophrenia with earlier onset is associated with greater numbers of negative symptoms throughout life. In this sample of patients, chronically hospitalized until death, neuroleptic drugs failed to effect a persistent decrease in positive symptoms. Copyright (c) 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17215594     DOI: 10.1159/000098488

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  12 in total

Review 1.  Very poor outcome schizophrenia: clinical and neuroimaging aspects.

Authors:  Serge A Mitelman; Monte S Buchsbaum
Journal:  Int Rev Psychiatry       Date:  2007-08

2.  Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components.

Authors:  Ying-Jiun J Chen; Madeleine A Johnson; Michael D Lieberman; Rose E Goodchild; Scott Schobel; Nicole Lewandowski; Gorazd Rosoklija; Ruei-Che Liu; Jay A Gingrich; Scott Small; Holly Moore; Andrew J Dwork; David A Talmage; Lorna W Role
Journal:  J Neurosci       Date:  2008-07-02       Impact factor: 6.167

3.  Neural substrate of unrelenting negative symptoms in schizophrenia: a longitudinal resting-state fMRI study.

Authors:  Mingli Li; Wei Deng; Tushar Das; Yinfei Li; Liansheng Zhao; Xiaohong Ma; Yingcheng Wang; Hua Yu; Xiaojing Li; Ya-Jing Meng; Qiang Wang; Lena Palaniyappan; Tao Li
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-11-11       Impact factor: 5.270

4.  Fetal irradiation interferes with adult cognition in the nonhuman primate.

Authors:  Harriet R Friedman; Lynn D Selemon
Journal:  Biol Psychiatry       Date:  2010-07-01       Impact factor: 13.382

Review 5.  Neurobiological background of negative symptoms.

Authors:  Silvana Galderisi; Eleonora Merlotti; Armida Mucci
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-03-24       Impact factor: 5.270

Review 6.  Managing Negative Symptoms of Schizophrenia: How Far Have We Come?

Authors:  Joshua T Kantrowitz
Journal:  CNS Drugs       Date:  2017-05       Impact factor: 5.749

7.  Differential Effect of Community Rehabilitation Reform on Hospitalizations of Patients with Chronic Psychotic Disorders With and Without Substance Use Disorder, Israel, 1991-2016.

Authors:  S Florentin; Y Neumark; S Raskin; T Bdolah-Abram; P Rosca
Journal:  Adm Policy Ment Health       Date:  2021-03

8.  Repeated measurements of cerebral blood flow in the left superior temporal gyrus reveal tonic hyperactivity in patients with auditory verbal hallucinations: a possible trait marker.

Authors:  Philipp Homan; Jochen Kindler; Martinus Hauf; Sebastian Walther; Daniela Hubl; Thomas Dierks
Journal:  Front Hum Neurosci       Date:  2013-06-25       Impact factor: 3.169

9.  Abnormal Degree Centrality of Bilateral Putamen and Left Superior Frontal Gyrus in Schizophrenia with Auditory Hallucinations: A Resting-state Functional Magnetic Resonance Imaging Study.

Authors:  Cheng Chen; Hui-Ling Wang; Shi-Hao Wu; Huan Huang; Ji-Lin Zou; Jun Chen; Tian-Zi Jiang; Yuan Zhou; Gao-Hua Wang
Journal:  Chin Med J (Engl)       Date:  2015-12-05       Impact factor: 2.628

10.  Increased regional homogeneity modulated by metacognitive training predicts therapeutic efficacy in patients with schizophrenia.

Authors:  Xiaoxiao Shan; Rongyuan Liao; Yangpan Ou; Pan Pan; Yudan Ding; Feng Liu; Jindong Chen; Jingping Zhao; Wenbin Guo; Yiqun He
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-03-25       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.